Table 1.
Transgene | Acinar | Glandular | Papillary | Solid | Adenosquamous | Pilar | Type P | Myoepithelial |
---|---|---|---|---|---|---|---|---|
ErbB2/Neu (n = 12) | 0 | 0 | 1 | 11 | 0 | 0 | 0 | 0 |
activated Neu (n = 5) | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
Neu mutants (n = 25) | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 |
ErbB2 and PR (n = 5) | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
ErbB2 and ErbB3 (n = 5) | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
PyV-mt (n = 49) | 2 | 8 | 5 | 29 | 2 | 2 | 1 | 0 |
Ras (n = 6) | 1 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
(n = 107) | 3 | 8 | 6 | 85 | 2 | 2 | 1 | 0 |
(100%) | (3%) | (7%) | (6%) | (79%) | (2%) | (2%) | (1%) | (0%) |